These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 214712)

  • 21. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 22. [Kainic acid: an agent for studying the brain].
    Sytinskiĭ IA; Turovskiĭ VS
    Usp Sovrem Biol; 1982; 93(2):253-69. PubMed ID: 7048784
    [No Abstract]   [Full Text] [Related]  

  • 23. Supersensitivity of the GABA receptor in the frog spinal cord, as induced by kainic acid.
    Ono H; Akahane K; Fukuda H; Kudo Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 76(2):231-6. PubMed ID: 6140100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite turning effects of dainic and ibotenic acid injected in the rat substantia nigra.
    Porceddu ML; Piacente B; Morelli M; Di Chiara G
    Neurosci Lett; 1979 Dec; 15(2-3):271-6. PubMed ID: 231244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of kainic acid on benzodiazepine receptors, GABA receptors, and GABA-modulin in the cerebellar cortex.
    Biggio G; Corda MG; De Montis G; Gessa GL
    Adv Biochem Psychopharmacol; 1980; 21():265-70. PubMed ID: 6246741
    [No Abstract]   [Full Text] [Related]  

  • 26. Gamma-aminobutyric acid turnover in rat striatum: effects of glutamate and kainic acid.
    Giorgi O; Meek JL
    J Neurochem; 1984 Jan; 42(1):215-20. PubMed ID: 6139420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological augmentation of acetylcholine levels in kainate-lesioned rat striatum.
    London ED; Coyle JT
    Biochem Pharmacol; 1978; 27(24):2962-5. PubMed ID: 32892
    [No Abstract]   [Full Text] [Related]  

  • 28. Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.
    Schwarcz R; Fuxe K; Agnati LF; Hökfelt T; Coyle JT
    Brain Res; 1979 Jul; 170(3):485-95. PubMed ID: 37986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra.
    Biggio G; Corda MG; Concas A; Gessa GL
    Brain Res; 1981 Sep; 220(2):344-9. PubMed ID: 6269689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity.
    Iadarola MJ; Gale K
    Mol Cell Biochem; 1981 Sep; 39():305-29. PubMed ID: 6273710
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra.
    Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
    Nature; 1983 Nov 3-9; 306(5938):57-60. PubMed ID: 6314146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABA agonists and potential antagonists related to muscimol.
    Arnt J; Krogsgaard-Larsen P
    Brain Res; 1979 Nov; 177(2):395-400. PubMed ID: 227538
    [No Abstract]   [Full Text] [Related]  

  • 33. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal-glial contributions to transmitter amino acid metabolism: studies with kainic acid-induced lesions of rat striatum.
    Nicklàs WJ; Nunez R; Berl S; Duvoisin R
    J Neurochem; 1979 Oct; 33(4):839-44. PubMed ID: 39980
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of endogenous level, uptake and release of taurine after intrastriatal kainic acid injection.
    Placheta P; Singer E; Schönbeck G; Heckl K; Karobath M
    Neuropharmacology; 1979 Apr; 18(4):399-402. PubMed ID: 450205
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
    Porceddu ML; Corda MG; Sanna E; Biggio G
    Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of kainic acid on somatostatin, GABAergic and cholinergic neurons in the rat striatum.
    Araki M; McGeer PL; McGeer EG
    Neurosci Lett; 1985 Jan; 53(2):197-202. PubMed ID: 2858835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.
    Coyle JT; Schwarcz R; Bennett JP; Campochiaro P
    Prog Neuropsychopharmacol; 1977; 1(1-2):13-30. PubMed ID: 214805
    [No Abstract]   [Full Text] [Related]  

  • 39. Defense reaction mediated by NMDA mechanisms in the inferior colliculus is modulated by GABAergic nigro-collicular pathways.
    Nobre MJ; Lopes MG; Brandão ML
    Brain Res; 2004 Feb; 999(1):124-31. PubMed ID: 14746929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histofluorescence of kainic acid-induced striatal lesions.
    Meibach RC; Brown L; Brooks FH
    Brain Res; 1978 Jun; 148(1):219-23. PubMed ID: 656926
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.